CLOV

3.70

0.80% -0.03

Dopo l'orario di chiusura: 3.67 -0.03 -0.81%

Clover Health Investments Corp (CLOV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CLOV Giù? Forum Previsione

Precedente Chiudi:

$3.73

Aprire:

$3.7

Volume 24 ore:

4.65M

Relative Volume:

0.81

Capitalizzazione di mercato:

$1.89B

Reddito:

$1.70B

Utile/perdita netta:

$-123.70M

Rapporto P/E:

-13.89

EPS:

-0.2663

Flusso di cassa netto:

$-178.21M

1 W Prestazione:

+1.09%

1M Prestazione:

-10.63%

6M Prestazione:

+31.21%

1 anno Prestazione:

+366.58%

Intervallo 1D:

$3.675

$3.84

Intervallo di 1 settimana:

$3.54

$3.91

Portata 52W:

$0.606

$4.87

Clover Health Investments Corp Stock (CLOV) Company Profile

Nome

Clover Health Investments Corp

Settore

Healthcare (1167)

Industria

Healthcare Plans (14)

Telefono

(201) 432-2133

Indirizzo

3401 MALLORY LANE, SUITE 210, FRANKLIN

Dipendente

570

Cinguettio

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

CLOV's Discussions on Twitter

Confronta CLOV con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CLOV Clover Health Investments Corp	3.70	1.89B	1.70B	-123.70M	-178.21M	-0.2663
UNH Unitedhealth Group Inc	515.72	476.23B	400.28B	14.41B	20.71B	15.50
ELV Elevance Health Inc	431.95	98.20B	176.81B	5.98B	4.55B	25.61
CI Cigna Group	324.74	88.04B	244.38B	3.43B	8.96B	12.24
CVS Cvs Health Corp	67.59	85.19B	372.81B	4.61B	6.33B	3.66
HUM Humana Inc	270.38	32.63B	117.76B	1.21B	2.39B	9.95

Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-17	Iniziato	Craig Hallum	Buy
2024-10-07	Iniziato	UBS	Neutral
2022-02-02	Iniziato	Canaccord Genuity	Buy
2022-02-02	Aggiornamento	Cowen	Underperform → Market Perform
2022-01-19	Iniziato	SVB Leerink	Mkt Perform
2022-01-10	Ripresa	Citigroup	Neutral
2022-01-07	Downgrade	Credit Suisse	Neutral → Underperform
2021-09-10	Iniziato	Cowen	Underperform
2021-09-02	Ripresa	Citigroup	Neutral
2021-07-12	Downgrade	JP Morgan	Neutral → Underweight
2021-06-10	Downgrade	BofA Securities	Neutral → Underperform
2021-05-17	Downgrade	BofA Securities	Buy → Neutral
2021-03-09	Iniziato	Credit Suisse	Neutral
2021-02-02	Iniziato	Citigroup	Buy
2021-02-01	Iniziato	JP Morgan	Neutral

Mostra tutto

Clover Health Investments Corp Borsa (CLOV) Ultime notizie

Mar 25, 2025

Why Kindly MD (KDLY) Skyrocketed on Monday? - Yahoo Finance

Mar 25, 2025

Mar 22, 2025

Is Clover Health Investments (CLOV) the Best Stock to Invest in for a Stock Market Game? - MSN

Mar 22, 2025

Mar 19, 2025

3 Reasons CLOV Is Risky And 1 Stock To Buy Instead - Barchart

Mar 19, 2025

Mar 18, 2025

12 Best Stocks to Invest in for a Stock Market Game - Insider Monkey

Mar 18, 2025

Q4 Earnings Outperformers: Clover Health (NASDAQ:CLOV) And The Rest Of The Health Insurance Providers Stocks - Barchart

Mar 18, 2025

Mar 17, 2025

3 Promising Penny Stocks With Market Caps Over $1B - Simply Wall St

Mar 17, 2025

Mar 13, 2025

Is Clover Health Investments, Corp. (CLOV) the Best Multibagger Stock to Buy in 2025? - Insider Monkey

Mar 13, 2025

Mar 12, 2025

Clover Health director sells $722,000 in stock - Investing.com India

Mar 12, 2025

Clover Health director sells $722,000 in stock By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 11, 2025

12 Best Multibagger Stocks to Buy in 2025 - Insider Monkey

Mar 11, 2025

Clover Health at Leerink Global Healthcare: Tech-Driven Medicare Growth - Investing.com

Mar 11, 2025

Mar 08, 2025

Clover Health general counsel sells $199,500 in stock By Investing.com - Investing.com Australia

Mar 08, 2025

Clover Health’s CEO of home care sells $276,000 in stock By Investing.com - Investing.com Australia

Mar 08, 2025

Missed the Hims & Hers Rally? Clover Health Could Be Next - MSN

Mar 08, 2025

Insider Moves: Clean Energy, Warner Bros, Clover Health, Corning, TJX - TipRanks

Mar 08, 2025

Mar 07, 2025

Clover Health’s CEO of home care sells $276,000 in stock - Investing.com

Mar 07, 2025

Clover Health general counsel sells $199,500 in stock - Investing.com

Mar 07, 2025

After ‘Really Good’ Year, Insurtechs Look to Continue Growth in 2025 - MMITNetwork

Mar 07, 2025

Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth - Seeking Alpha

Mar 07, 2025

Mar 04, 2025

Decoding Clover Health Investments Corp (CLOV): A Strategic SWOT Insight - GuruFocus.com

Mar 04, 2025

Canaccord lifts Clover Health stock target to $4.50, maintains buy By Investing.com - Investing.com Australia

Mar 04, 2025

Clover Health’s Earnings Call Highlights Profitability and Growth - TipRanks

Mar 04, 2025

Clover Health Investments (NASDAQ:CLOV) Given New $4.50 Price Target at Canaccord Genuity Group - Defense World

Mar 04, 2025

Mar 03, 2025

Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians - The Manila Times

Mar 03, 2025

Can This Google Cloud Partnership Help Clover Health Solve the 28-Hour Administrative Burden Crushing Doctors? - StockTitan

Mar 03, 2025

Canaccord lifts Clover Health stock target to $4.50, maintains buy - Investing.com

Mar 03, 2025

CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-K Report - TradingView

Mar 03, 2025

Feb 28, 2025

Clover Health Investments (NASDAQ:CLOV) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Feb 28, 2025

Clover Health Investments (NASDAQ:CLOV) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Feb 28, 2025

Clover Health Investments (CLOV) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025

Clover Health Reports Q4 2024 Revenue of $337 Million, Missing E - GuruFocus.com

Feb 28, 2025

Clover Health Investments CorpOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire

Feb 28, 2025

CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises - Nasdaq

Feb 28, 2025

Clover Health Investments Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 28, 2025